The purpose of this study is to determine if there is a link between liver cancer recurrences after liver transplant, in a specific population of patients who have received TACE therapy.
Principal Investigator: Ari Cohen, MD
|Full Protocol Title||An observational study to evaluate patients receiving transarterial chemoembolization (TACE) therapy to define the link between tumor-elicited peripheral cell populations, and the risk of hepatocellular carcinoma (HCC) recurrence, following orthotropic liver transplantation (OLT).|
Main Campus - Jefferson Highway
|Change in Care||Participating will NOT change your care|